Artelo Biosciences, Inc. (ARTL) Misses Q1 EPS by 59c

Artelo Biosciences, Inc. (NASDAQ: ARTL) reported Q1 EPS of ($0.72), $0.59 worse than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Artelo Biosciences, Inc. (ARTL) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• BMO Capital Upgrades CES Energy Solutions Corp. (CEU:CN) (CESDF) to Outperform
• U.S. Physical Therapy (USPH) Reiterated at Market Outperform by Citizens